Similar Search Results

Models of Palliative Care Service Delivery: What is Most Cost Effective?

Bosanquet, Nick - In: Disease Management and Health Outcomes 10 (2002) 6, pp. 349-353

Palliative care has been through a difficult development process, but now has the evidence and experience base to make a contribution in the changing health environment. There has now been a great deal of experience with different types of care, and research has shown that patients strongly...

Persistent link: https://www.econbiz.de/10005448919

Patient Self-Reports in Pharmacoeconomic Studies: Their Use and Impact on Study Validity

Evans, Christopher; Crawford, Bruce - In: PharmacoEconomics 15 (1999) 3, pp. 241-256

consumption are recalled to the same degree: medication use tends to be recalled with less accuracy than hospitalisation. In terms …

Persistent link: https://www.econbiz.de/10005448987

Use and Cost of Hospital and Community Service Provision for Children with HIV Infection at an English HIV Referral Centre

Beck, Eduard J.; Mandalia, Sundhiya; Griffith, Rebecca; … - In: PharmacoEconomics 17 (2000) 1, pp. 53-69

Objective: To describe the use of hospital and community services for children infected with HIV and estimate the cost per patient-year by stage of HIV infection during the era of antiretroviral monotherapy. Design: Data on the use of hospital services were collected from case notes; the use of...

Persistent link: https://www.econbiz.de/10005449015

Counting the Costs of Drug-Related Adverse Events

White, T. Jeffrey; Arakelian, Annet; Rho, Jay P. - In: PharmacoEconomics 15 (1999) 5, pp. 445-458

Adverse drug events occur frequently and lead to a significant number of fatalities each year. It has been estimated that fatalities directly attributable to adverse drug reactions are the fourth to sixth leading cause of death in US hospitals, exceeding deaths caused by pneumonia and diabetes....

Persistent link: https://www.econbiz.de/10005449050

Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from th...

Schadlich, Peter K.; Huppertz, Eduard; Brecht, Josef Georg - In: PharmacoEconomics 14 (1998) 6, pp. 653-669

variable was broad and the hospitalisation impact of adding ramipril to conventional treatment was an independent variable with …

Persistent link: https://www.econbiz.de/10005449120

Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia: Results From a Randomised Clinical Trial

Hamilton, Susan H.; Revicki, Dennis A.; Edgell, Eric T.; … - In: PharmacoEconomics 15 (1999) 5, pp. 469-480

Objective: The purpose of this study was to compare, from the payor perspective, the clinical and economic outcomes of olanzapine to those of haloperidol for the treatment of schizophrenia. Design and setting: Clinical, quality-of-life and resource utilisation data were prospectively collected...

Persistent link: https://www.econbiz.de/10005449144

The Use and Cost of HIV Service Provision in England in 1996

Beck, Eduard J.; Tolley, Keith; Power, Amanda; … - In: PharmacoEconomics 14 (1998) 6, pp. 639-652

Objective: The aim of the study was to measure the use and estimate the cost of HIV service provision in England. Design and Setting: Standardised activity and case-severity data were collected prospectively in 10 English HIV clinics (5 London and 5 non-London sites) for the periods 1 January...

Persistent link: https://www.econbiz.de/10005449215

Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference?

Goeree, Ron; Gafni, Amiram; Hannah, Mary; Myhr, Terri; … - In: PharmacoEconomics 15 (1999) 6, pp. 561-572

Objective: The objectives of this study were 1. to develop a conceptual framework for selecting hospitals for unit cost estimates in national and international multicentre trials and 2. to test the impact of alternative hospital selection on the cost results. Design and setting: Within the...

Persistent link: https://www.econbiz.de/10005449283

Modelling the Potential Economic Impact of Viral Load-Driven Triple Drug Combination Antiretroviral Therapy

Anis, Aslam H.; Hogg, Robert S.; Wang, Xiao-hua; Yip, Benita - In: PharmacoEconomics 13 (1998) 6, pp. 697-705

(including a protease inhibitor) antiretroviral therapy on incremental drug and hospitalisation costs among individuals with HIV … therapy net of hospitalisation and testing costs in 1996 Canadian dollars ($Can). The utilisation pattern of drugs and … in hospitalisation remained in multivariate models, adjusting for prior AIDS-defining illnesses and gender. The average …

Persistent link: https://www.econbiz.de/10005449286

Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes: In Patients with Bipolar I Disorder in France

de Zelicourt, Marie; Dardennes, Roland; Verdoux, Helene; … - In: PharmacoEconomics 21 (2003) 15, pp. 1081-1090

assess the frequency of hospitalisation and the inpatient care costs associated with manic episodes in patients with bipolar …. Additional epidemiological references were identified from published studies and textbooks. Data on frequency of hospitalisation … Conclusion: Our study highlights the lack of medical and economic data on the frequency and hospitalisation-related costs of …

Persistent link: https://www.econbiz.de/10005449290